Insider Transactions in Q4 2022 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
6,729
-11.93%
|
$760,377
$113.8 P/Share
|
|
Dec 30
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
15,185
+21.22%
|
-
|
|
Dec 30
2022
|
Jeff Himawan Director |
SELL
Bona fide gift
|
Direct |
2,230
-21.88%
|
-
|
|
Dec 30
2022
|
Aaron Cox EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,758
-44.12%
|
$3,249,654
$113.8 P/Share
|
|
Dec 30
2022
|
Aaron Cox EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,906
+49.89%
|
-
|
|
Dec 30
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,313
-32.02%
|
$4,442,369
$113.8 P/Share
|
|
Dec 30
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
88,733
+41.95%
|
-
|
|
Dec 30
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
9,449
-36.31%
|
$1,067,737
$113.8 P/Share
|
|
Dec 30
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
19,055
+42.27%
|
-
|
|
Dec 15
2022
|
Aaron Cox EVP, Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
4,774
-94.52%
|
-
|
|
Dec 13
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
30,169
-26.55%
|
$3,378,928
$112.61 P/Share
|
|
Dec 13
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,251
+26.58%
|
$674,279
$29.52 P/Share
|
|
Dec 12
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
28,352
-15.77%
|
$3,147,072
$111.45 P/Share
|
|
Nov 01
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,503
-11.84%
|
$346,689
$63.18 P/Share
|
|
Nov 01
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,421
+21.09%
|
-
|